C HIGHPRECISION (00591) announced its interim results, with a net profit of 3.788 million yuan, a year-on-year decrease of 76.04%.
China High Precision (00591) announced its interim results for the six months ended December 31, 2025. The company reported a revenue of 85.48 million yuan, a decrease of 26.48% year-on-year; a net profit of 3.788 million yuan, a decrease of 76.04% year-on-year; and earnings per share of 0.37 yuan.
C HIGHPRECISION (00591) announced its interim results for the six months ending on December 31, 2025, with revenue of 85.48 million yuan, a decrease of 26.48% year-on-year; net profit of 3.788 million yuan, a decrease of 76.04% year-on-year; and earnings per share of 0.37 cents.
The announcement stated that the decrease in revenue was mainly due to delays in projects leading to a decrease in sales of industrial automation instrument products in the petroleum and petrochemical industries, partially offset by a slight increase in entrusted processing services for automation instruments and technical products. Faced with global economic uncertainty, the group continues to be affected by various challenges brought about by the slowdown in economic growth for industrial automation instruments.
The decrease in net profit was primarily due to the decrease in sales of industrial automation instrument products and an increase in net foreign exchange losses, partially offset by the following factors: (i) other income mainly increased due to the reversal of provisions for Chinese medical insurance and Chinese housing provident fund, and (ii) reversal and reduction in inventory provisions amounted to approximately 764,000 yuan.
Related Articles

DETAI NEWENERGY (00559) announces its interim financial results with a net profit of approximately 10,000 Hong Kong dollars, a decrease of 99.84% year-on-year.

HC GROUP (02280): Some shares of Beijing Zhaoxin held by shareholders of Beijing Zhaoxin have been frozen.

CR MEDICAL (01515): Wang Yuexing appointed as executive director.
DETAI NEWENERGY (00559) announces its interim financial results with a net profit of approximately 10,000 Hong Kong dollars, a decrease of 99.84% year-on-year.

HC GROUP (02280): Some shares of Beijing Zhaoxin held by shareholders of Beijing Zhaoxin have been frozen.

CR MEDICAL (01515): Wang Yuexing appointed as executive director.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


